Skip to main content

Table 3 CMap analysis identified potential therapeutic drugs for the H-NUSAP1 group

From: Evaluate the diagnostic and prognostic value of NUSAP1 in papillary thyroid carcinoma and identify the relationship with genes, proteins, and immune factors

Rank Score Type Name Description
1 − 99.93 cp Palbociclib CDK inhibitor
2 − 99.75 cp Purvalanol-a CDK inhibitor
3 − 99.65 cp Aminopurvalanol-a Tyrosine kinase inhibitor
4 − 99.61 cp Floxuridine DNA synthesis inhibitor
5 − 99.54 cp L-690488 Inositol monophosphatase inhibitor
6 − 99.33 cp Bisbenzimide DNA-binding agent
7 − 99.19 cp JAK3-inhibitor-VI JAK inhibitor
8 − 99.08 cp Pyrimethamine Dihydrofolate reductase inhibitor
9 − 99.01 cp Selumetinib MEK inhibitor
10 − 99.01 cp Teniposide Topoisomerase inhibitor